[Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
The cases previously described with tranylcipromine and phenelzine abuse have been reviewed and the main epidemiological, clinical and diagnostic characteristics of them have been analyzed. The aim is to obtain a profile of the patients at risk to develop this kind of problem. In addition, several important questions and the most accepted pharmacological bases of this drugs' addiction are revised.
D000328:Adult; D000368:Aged; D003866:Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D010624:Phenelzine / Q000009:adverse effects* / Q000627:therapeutic use*; D019966:Substance-Related Disorders / Q000209:etiology*; D014191:Tranylcypromine / Q000009:adverse effects* / Q000627:therapeutic use*
D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D010624:Phenelzine
Abuso de antidepresivos inhibidores de la monoaminooxidasa (IMAO): una revisión crítica.